Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Assets (2016 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Return on Assets for 12 consecutive years, with 0.31% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets fell 70.0% year-over-year to 0.31%, compared with a TTM value of 0.31% through Dec 2025, down 70.0%, and an annual FY2025 reading of 0.28%, down 80.0% over the prior year.
  • Return on Assets was 0.31% for Q4 2025 at Agios Pharmaceuticals, down from 0.28% in the prior quarter.
  • Across five years, Return on Assets topped out at 1.32% in Q4 2021 and bottomed at 0.46% in Q2 2024.
  • Average Return on Assets over 5 years is 0.21%, with a median of 0.0% recorded in 2022.
  • The sharpest move saw Return on Assets soared 148bps in 2021, then crashed -115bps in 2022.
  • Year by year, Return on Assets stood at 1.32% in 2021, then plummeted by -100bps to 0.0% in 2022, then tumbled by -11386bps to 0.37% in 2023, then surged by 205bps to 0.39% in 2024, then plummeted by -180bps to 0.31% in 2025.
  • Business Quant data shows Return on Assets for AGIO at 0.31% in Q4 2025, 0.28% in Q3 2025, and 0.43% in Q2 2025.